CEO Serge Saxonov highlighted strong growth across platforms, with total revenue for Q4 2023 reaching $184 million, an 18% increase year-over-year. Spatial products contributed significantly, with ...

Q4 2024 Earnings Call Transcript February 12, 2025 10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.4 ...

driven by new product launches like Visium HD and Xenium Prime 5K. The company reorganized its sales force to better support ...

Serge Saxonov, PhD, 10x Genomics co-founder and CEO 10x’s co ... cell spatial imaging platform and commercially launched Visium HD (a new version of its Visium Spatial Gene Expression product ...

10x Genomics Price Performance Shares of TXG opened at $12.31 on Tuesday. The firm has a market cap of $1.49 billion, a PE ratio of -8.05 and a beta of 1.85. The stock’s fifty day moving average ...